Smith & Nephew Plc: (NYSE: SNN)

$59.74

-0.43 (-0.72%)

Volume 22,394

May 21 04:01 PM ET

Zacks Rank: 3-Hold

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		59.44 - 59.92
	
		52wk Low - High
		44.84 - 60.22
	
		Previous Close
		60.17
	
		Avg. Volume
		59,692
	
		Industry
		MED PRODUCTS
	
		Market Cap
		10.89 B
	
		Div - Yield
		1.27 - 2.12
	
		Beta
		0.65
	
		PE (Forward)
		15.52
	
		Current Year Est.
		3.88
	
		Quarterly Earnings ESP 
		2.17%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		3
Hold

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		179 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 05/16/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            PE (Forward)
                            15.52
                        
                            PEG Ratio
                            2.25
                        
                            Current Year Est.
                            3.88
                        
                            Current Quarter Estimate
                            0.92
                        
                            Most Accurate Estimate
                            0.94
                        
                            Earnings ESP 
                            2.17%
                        
                            Next Earnings Report Date
                            08-08-2013
                        
                            EPS Last Year
                            3.75
                        
                            Expected Earnings Growth
                            6.90%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physician advantage and real patient benefits.  A continuous process of supplying new and innovative products is supported by substantial R&D investment to deliver new levels of healing to patients throughout the world   
Full SNN Company Report

        
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
SNN Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (12/2013)	Next Year (12/2014)
Average Estimate	0.92	0.87	3.88	4.24
Number of Estimates	4	4	6	4
Low Estimate	0.86	0.82	3.81	4.12
High Estimate	0.95	0.90	3.95	NA
Year Ago EPS	0.91	0.83	3.77	3.88
EPS Growth	0.82%	5.12%	2.83%	9.24%

More SNN Estimates

Average Earnings Estimates for SNN

EPS Growth for SNN

Industry Analysis

Name	Symbol	Previous Close
SMITH & NEPHEW	SNN	60.17
CONCEPTUS INC	CPTS	30.92
ATRICURE INC	ATRC	9.05
INVIVO THERAPT	NVIV	2.89
TRANS1 INC	TSON	1.69
ABAXIS INC	ABAX	44.67
ADVAXIS INC	ADXS	0.05
BAXTER INTL	BAX	72.94
BIO-RAD LABS -A	BIO	116.41
BIOLIFE SOL INC	BLFS	0.41

Sector:Medical>> Industry:MED PRODUCTS

COMPARE TICKER vs. Its Peers

Zacks Commentary

SNN Sales Beat but Earnings Miss on Weak Results

May 06, 2013

Zimmer Beats Earnings, Misses Revenue

Apr 25, 2013

SNN Acquires Brazilian Distributor

Apr 04, 2013

Smith & Nephew Extends Portfolio

Mar 27, 2013

SNN Rolls Out Journey II BCS Knee

Mar 26, 2013

WMGI Beats Est, Reports Profit

Feb 25, 2013

Smith & Nephew Beats in 4Q

Feb 12, 2013

Covidien Issues STAR Trial Data

Feb 08, 2013

More SNN Zacks Commentary

Financials

EPS TTM	3.75
Sales	4,137
Net Income	711
Price/Earnings	16.05
Price/Book	2.75
Price/Cash Flow	10.79
Price/Sales	2.63

More SNN Financials

News

Smith & Nephew Q1 profit decreases - Datamonitor

May 16, 2013

Smith & Nephew Shares Climbing Higher, Up 1.1% - Financial News Network Online - Market Movers

May 15, 2013

65-- SURGERY SUPPORT ACTION - SMITH & NEPHEW TOTAL KNEE - Fedbizopps

May 14, 2013

SURGERY SUPPORT ACTION - SMITH & NEPHEW TOTAL KNEE - Fedbizopps

May 14, 2013

Smith & Nephew Makes a Move: Up 1.3% - Financial News Network Online - Market Movers

May 8, 2013

Smith & Nephew Meets on the Top Line, Misses Where it Counts - TheMotleyFool

May 6, 2013

Emerging Markets Heat Up for Device Makers - TheMotleyFool

May 3, 2013

Profits Drop 4% at Smith & Nephew - TheMotleyFool

May 2, 2013

See All News Stories on SNN

Broker Recommendations

Current ABR	2.78
ABR (Last Week)	2.78
# of recs in ABR	9
Average Target Price	56.57
Industry Rank by ABR	179 out of 265
Rank in Industry	5 out of 72

More SNN Broker Recommendations

Day Low - High	59.44 - 59.92
52wk Low - High	44.84 - 60.22
Previous Close	60.17
Avg. Volume	59,692
Industry	MED PRODUCTS
Market Cap	10.89 B
Div - Yield	1.27 - 2.12
Beta	0.65
PE (Forward)	15.52
Current Year Est.	3.88
Quarterly Earnings ESP	2.17%

PE (Forward)	15.52
PEG Ratio	2.25
Current Year Est.	3.88
Current Quarter Estimate	0.92
Most Accurate Estimate	0.94
Earnings ESP	2.17%
Next Earnings Report Date	08-08-2013
EPS Last Year	3.75
Expected Earnings Growth	6.90%

Username: Password:

Remember me [?]

Smith & Nephew Plc: (NYSE: SNN)

$59.74

-0.43 (-0.72%)

Volume 22,394

May 21 04:01 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description